The French vaccine developer’s latest shareholder notification, filed at the end of August, offers a snapshot of a capital structure...

The most telling detail in Amphenol's recent insider filings isn't the dollar figure attached to CEO Richard Adam Norwitt's June...

The Swiss chocolatier has long sold itself on indulgence, not discounting. But the first half of this year tells a...

The battle for Commerzbank has entered a distinctly personal phase. Chief executive Bettina Orlopp has made clear she will walk...

The arithmetic of defence investing has rarely looked more contradictory than it does at Hensoldt right now. The Munich-based sensor...

The regulatory squeeze on artificial intelligence is turning into a business opportunity for q.beyond, with the Cologne-based IT services firm...

The numbers tell a stark story of disconnect. EssilorLuxottica's first-half revenue climbed 9.7 percent at constant currencies to €14.818 billion,...

For all the noise surrounding Nvidia's blockbuster acquisition of Hugging Face, the most telling detail of the company's recent activity...

The administrative machinery of US healthcare reimbursement rarely moves markets — but for Outlook Therapeutics, a single coding application now...

The disconnect between Rocket Lab's operational cadence and its stock price has rarely been starker. While the company notched its...